HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V Mohamed-Ali Selected Research

Adiponectin

5/2009n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V Mohamed-Ali Research Topics

Disease

7Obesity
10/2011 - 02/2000
5Insulin Resistance
10/2011 - 02/2000
5Inflammation (Inflammations)
10/2011 - 02/2000
5Necrosis
11/2001 - 02/2000
2Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2011 - 07/2004
1Water Intoxication
09/2018
1Cardiovascular Diseases (Cardiovascular Disease)
10/2011
1Hypertrophy
05/2009
1Body Weight (Weight, Body)
05/2009
1Thrombocytosis (Thrombocythemia)
10/2004
1Lymphopenia (Lymphocytopenia)
10/2004
1Heart Diseases (Heart Disease)
05/2004
1Neoplasms (Cancer)
06/2002
1Weight Loss (Weight Reduction)
06/2002
1Cachexia
06/2002
1Vascular Diseases (Vascular Disease)
11/2001
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2001
1Hypothyroidism
06/2000
1Hyperthyroidism
06/2000
1Hypertension (High Blood Pressure)
02/2000
1Starvation
02/2000
1Coronary Disease (Coronary Heart Disease)
02/2000
1Acute-Phase Reaction
02/2000
1Acute Coronary Syndrome
02/2000
1Abdominal Obesity
02/2000
1Atherosclerosis
02/2000
1Vascular System Injuries
02/2000

Drug/Important Bio-Agent (IBA)

10Interleukin-6 (Interleukin 6)IBA
12/2008 - 02/2000
4CytokinesIBA
12/2008 - 02/2000
3Glucose (Dextrose)FDA LinkGeneric
10/2011 - 09/2000
3C-Reactive ProteinIBA
07/2004 - 02/2000
3Fibrinogen (Factor I)FDA Link
07/2004 - 02/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2001 - 02/2000
3LeptinIBA
11/2000 - 02/2000
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
10/2011 - 02/2006
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
10/2011 - 05/2009
2LipidsIBA
10/2011 - 05/2009
2Insulin (Novolin)FDA Link
07/2004 - 09/2000
1SteroidsIBA
09/2018
1protectin D1IBA
10/2011
1Rosiglitazone (Avandia)FDA Link
05/2009
1CeramidesIBA
05/2009
1GlycogenIBA
05/2009
1ThiazolidinedionesIBA
05/2009
1PPAR gammaIBA
05/2009
1AdiponectinIBA
05/2009
1Eicosapentaenoic AcidIBA
02/2006
1Docosahexaenoic AcidsIBA
02/2006
1Plant Oils (Vegetable Oils)IBA
02/2006
1EndotoxinsIBA
10/2004
1Pharmaceutical PreparationsIBA
10/2004
1Triglycerides (Triacylglycerol)IBA
07/2004
1ProinsulinIBA
07/2004
1Insulin-Like Growth Factor Binding Protein 3IBA
06/2002
1Insulin-Like PeptidesIBA
06/2002
1Insulin-Like Growth Factor I (IGF-1)IBA
06/2002
1Adrenergic Receptors (Adrenergic Receptor)IBA
12/2001
1Cytokine Receptors (Cytokine Receptor)IBA
11/2001
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
08/2001
1Interleukin-1 (Interleukin 1)IBA
02/2000
1Acute-Phase Proteins (Acute-Phase Protein)IBA
02/2000

Therapy/Procedure

1Complementary Therapies (Alternative Medicine)
05/2009
1Therapeutics
10/2004
1Aftercare (After-Treatment)
10/2004